TEAR - TearLab Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue24,99927,11928,01425,156
Cost of Revenue8,49510,59110,18810,825
Gross Profit16,50416,52817,82614,331
Operating Expenses
Research Development3,5874,6915,1526,951
Selling General and Administrative9,49420,78025,45434,284
Non Recurring----
Total Operating Expenses22,53738,18343,99055,293
Operating Income or Loss2,462-11,064-15,976-30,137
Income from Continuing Operations
Total Other Income/Expenses Net-4,713-5,037-3,944-3,092
Earnings Before Interest and Taxes2,462-11,064-15,976-30,137
Interest Expense--4,269-4,003-2,023
Income Before Tax-2,251-16,101-19,920-33,229
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-2,251-16,101-19,920-33,229
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-2,251-16,101-19,920-33,229
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-2,251-16,101-19,920-33,229